Rosacea: Common Questions and Answers

Area of Science:

• Dermatology
• Inflammatory Skin Diseases

Background:

• Rosacea is a prevalent chronic inflammatory skin condition affecting the central face.
• Its exact cause remains unknown, impacting approximately 5% of the population.
• Diagnosis relies on the 2017 National Rosacea Society guidelines, noting key signs like erythema, papules, and telangiectasia.

Purpose of the Study:

• To provide an overview of rosacea diagnosis and management.
• To highlight challenges in diagnosing rosacea in skin of color.
• To discuss current and emerging treatment strategies.

Main Methods:

• Review of diagnostic criteria for rosacea.
• Analysis of current topical and systemic treatment options.
• Discussion of maintenance care and trigger avoidance.

Main Results:

• Diagnostic delays can occur in skin of color due to visualization difficulties.
• Effective topical treatments include ivermectin, metronidazole, and azelaic acid.
• Systemic treatments involve beta blockers, doxycycline, and isotretinoin.

Conclusions:

• Rosacea management requires a multimodal approach including skincare, trigger avoidance, and targeted therapies.
• Early diagnosis and treatment are crucial for managing symptoms and improving quality of life.
• Referral for fixed phymatous changes and ocular rosacea is recommended.